Multiple Sclerosis (MS), a chronic autoimmune disease affecting the central nervous system, can have profound psychiatric implications. From mood disturbances to cognitive challenges, understanding the broader impact of MS is vital. The Journal of Clinical Psychiatry offers insights into the psychiatric aspects of MS, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with MS.
Multiple Sclerosis
Page 8
Recently published articles about Multiple Sclerosis
Webinar
What's Next for PPD Treatment | Inhaled Mebufotenin (GH001) Phase 2a Results
July 29, 2026
Kristina Deligiannidis, MD, presents phase 2a results for inhaled GH001 (mebufotenin), a psychedelic-based therapeutic that produced same-day remission of postpartum depression in an open-label trial, with rapid clearance from...